Tvardi Therapeutics (TVRD) Gross Margin (2022 - 2024)
Tvardi Therapeutics (TVRD) recorded Gross Margin of 100.00% in Q4 2024, up 20.24 percentage points from 79.76% a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Tvardi Therapeutics (TVRD) Gross Margin (2022 - 2024) Analysis & Trends
For FY2024, Tvardi Therapeutics reported Gross Margin of 91.31%, up 20.76 percentage points from FY2023.
- Across earlier years, Gross Margin came in at 70.56% in FY2023 (-12.09 pp) and 82.65% in FY2022.
- On a year-over-year basis, Gross Margin has increased for five consecutive quarters, with an average year-over-year change of +13.50 percentage points over the last eight quarters.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 45.08 percentage points in Q4 2023, against a drop of 20.45 percentage points in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 100.00% (Q3 2024), 100.00% (Q2 2024) and 70.96% (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Tvardi Therapeutics | 12.48 Mn | 12.48 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 100.00% |
| Sep 30, 2024 | 100.00% |
| Jun 30, 2024 | 100.00% |
| Mar 31, 2024 | 70.96% |
| Dec 31, 2023 | 79.76% |
| Sep 30, 2023 | 67.98% |
| Jun 30, 2023 | 79.55% |
| Mar 31, 2023 | 57.99% |
| Dec 31, 2022 | 34.68% |
| Sep 30, 2022 | 71.75% |
| Jun 30, 2022 | 100.00% |
| Mar 31, 2022 | 56.56% |
API Access
Tvardi Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=TVRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "TVRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=TVRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();